Nitric Oxide Donor, (+/-)-S-nitroso-N-acetylpenicillamine, Stabilizes Transactive Hypoxia-inducible Factor-1alpha by Inhibiting Von Hippel-Lindau Recruitment and Asparagine Hydroxylation
Overview
Pharmacology
Authors
Affiliations
We have confirmed that the NO donor (+/-)-S-nitroso-N-acetylpenicillamine (SNAP) stabilizes the transactive form of hypoxia-inducible factor-1alpha (HIF-1alpha), leading to the induction of HIF-1alpha target genes such as vascular endothelial growth factor and carbonic anhydrase 9. Activation of HIF-1alpha should require inhibition of the dual system that keeps it inactive. One is ubiquitination, which is triggered by hydroxylation of HIF-1alpha-proline and the subsequent binding of E3 ubiquitin ligase, the von Hippel Lindau (VHL) protein. The other is hydroxylation of HIF-1alpha-asparagine, which reduces the affinity of HIF-1alpha for its coactivator, cAMP responsive element binding protein/p300. We examined the effects of the NO donor SNAP on proline and asparagine hydroxylation of HIF-1alpha peptides by measuring the activities of the corresponding enzymes, HIF-1alpha-specific proline hydroxylase 2 (PHD2) and the HIF-1alpha-specific asparagine hydroxylase, designated factor inhibiting HIF-1alpha (FIH-1), respectively. We found that the SNAP did not prevent PHD2 from hydroxylating the proline of HIF-1alpha. Instead, it blocked the interaction between VHL and the proline-hydroxylated HIF-1alpha, but only when the reducing agents Fe(II) and vitamin C were limiting. The fact that the absence of cysteine 520 of HIF-1alpha abolishes its responsiveness to SNAP suggests that this residue mediates the inhibition by SNAP of the interaction between VHL and HIF-1alpha, presumably by S-nitrosylation of HIF-1alpha. Un-like PHD2, asparagine hydroxylation by FIH-1 was directly inhibited by SNAP, but again only when reducing agents were limiting. Substitution of cysteine 800 of HIF-1alpha with alanine failed to reverse the inhibitory effects of SNAP on asparagine hydroxylation, implying that FIH-1, not its substrate HIF-1alpha, is inhibited by SNAP.
The Role of HIF-1α in Bone Regeneration: A New Direction and Challenge in Bone Tissue Engineering.
You J, Liu M, Li M, Zhai S, Quni S, Zhang L Int J Mol Sci. 2023; 24(9).
PMID: 37175732 PMC: 10179302. DOI: 10.3390/ijms24098029.
Nguyen H, Koh J, Li H, Islas-Robles A, Meda Venkata S, Wang J FASEB J. 2021; 35(7):e21645.
PMID: 34105824 PMC: 8237315. DOI: 10.1096/fj.202002674RR.
COVID-19: Proposing a Ketone-Based Metabolic Therapy as a Treatment to Blunt the Cytokine Storm.
Bradshaw P, Seeds W, Miller A, Mahajan V, Curtis W Oxid Med Cell Longev. 2020; 2020:6401341.
PMID: 33014275 PMC: 7519203. DOI: 10.1155/2020/6401341.
Sanhueza C, Bennett J, Valenzuela-Valderrama M, Contreras P, Lobos-Gonzalez L, Campos A Cancers (Basel). 2020; 12(9).
PMID: 32825247 PMC: 7565942. DOI: 10.3390/cancers12092349.
Park H Toxicol Res. 2020; 24(2):101-107.
PMID: 32038783 PMC: 7006278. DOI: 10.5487/TR.2008.24.2.101.